Strix Group Plc Successful Placing to raise £190 million

STRIX GROUP PLC

Strix Group Plc, the designer, manufacturer and supplier of kettle safety controls and other complementary water temperature management components, is pleased to announce the successful pricing of its initial public offering (the “IPO”) and the placing (the “Placing”) of 190 million ordinary shares at 100 pence per share (the “Placing Price”) to raise £190 million. Trading on the AIM Market of the London Stock Exchange will commence on 8 August 2017 (“Admission”).

Highlights

· The Placing has raised £190 million via the placing of 190 million new ordinary shares at a placing price of 100 pence per share.

· The Company’s market capitalisation on Admission, based on the Placing Price, is expected to be £190 million.

· The Placing saw strong demand from a range of institutional investors.

· It is expected that dealings will commence on AIM at 8.00am on 8 August 2017. The ordinary shares will trade under the ticker “KETL” and the ISIN number is: IM00BF0FMG91.

Zeus Capital is acting as Nominated Adviser and Sole Broker to the Company.

Mark Bartlett, CEO of Strix Group Plc, commented:

I am delighted to announce that our initial public offering has been successful. We look forward to joining AIM on the 8th August and I would like to welcome our new shareholders to the Company.

The Placing and Admission to AIM will position the Company appropriately for the next stage of its development, in particular enabling us to invest in our new product development capabilities to the benefit of our valued customers. We look forward to being a public company and further growth across our business in existing and new markets.

To read the full RNS please click here

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

    HUTCHMED showcases new oncology data at ASCO 2025

    HUTCHMED (China) Limited is set to unveil groundbreaking data on key cancer therapies at the 2025 ASCO Annual Meeting, highlighting promising advancements in NSCLC and solid tumors.

    Ilika launches £3.8m fundraise including £0.5m Retail Offer

    Ilika Plc has successfully closed its accelerated bookbuild, raising approximately £3.3 million to enhance solid-state battery technology and commercial growth.

    Nuformix raises £210,000 to advance NXP002 and US Orphan Drug Application

    Nuformix plc (LON:NFX) aims to raise £210,000 through a conditional placing to advance its NXP002 inhalation treatment for IPF and PPF.

    Likewise grants over 3.1m shares under 2025 SAYE scheme

    Likewise Group plc (LON:LIKE) has successfully closed its 2025 Save As You Earn Scheme, granting options to 69 employees on over 3.1 million shares.

    Zotefoams reports record £50.7m revenue in strong start to 2025

    Zotefoams Plc reports strong sales growth of 8% and record revenue for the first four months of 2025, showcasing a successful strategic pivot into key markets.

    Ilika announces £3.5m fundraise via Placing and Retail Offer

    Ilika Plc, a leader in solid-state battery technology, plans to raise approximately £3.0 million through a new share placing and a retail offer for shareholders.

      Search

      Search